Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • ABVD plus rituximab versus ABV...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study

Bibliographic Details
Published in:Haematologica
Main Authors: Paolo Strati, Michelle A. Fanale, Yasuhiro Oki, Francesco Turturro, Luis E Fayad, Nancy L. Bartlett, Douglas E. Gladstone, Yvette L. Kasamon, Carol S. Portlock, Wyndham H. Wilson, Andre Goy, Anas Younes, Hun Ju Lee
Format: Article
Language:English
Published: Ferrata Storti Foundation 2019-02-01
Online Access:https://haematologica.org/article/view/8789
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/8789

Similar Items

  • Neutropenia and Neutropenic Complications in ABVD Chemotherapy for Hodgkin Lymphoma
    by: Bhanu Vakkalanka, et al.
    Published: (2011-01-01)
  • The Use of Filgrastim in Patients with Hodgkin Lymphoma Receiving ABVD
    by: Adam F. Binder, et al.
    Published: (2017-10-01)
  • ABVD versus Stanford V Regimen in Unfavorable Classical Hodgkins Lymphoma
    by: TOMMY SUPIT, et al.
    Published: (2013-12-01)
  • Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
    by: Diego Villa, et al.
    Published: (2018-12-01)
  • A case of blood triglyceride increased induced by ABVD therapy for classical Hodgkin lymphoma
    by: Ryo Yonezawa, et al.
    Published: (2023-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs